4166 Share Price Performance
NT$24.20
-11.65 (-32.50%)
Price NT$24.20
Share Pricen/a
Orient Pharma Co., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
4166 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Orient Pharma Co., Ltd. Key Details
About 4166
- Founded
- 2008
- Employees
- n/a
- CEO
- WebsiteView website
Orient Pharma Co., Ltd. engages in the development of new drugs in Taiwan and internationally. It offers cardiovascular drugs, such as Pitator and Tonvasca for lipid suppression, as well as Zulitor, a lipid lowering drug; psychotropic drugs, including Trokendi XR extended, Methydur, and powder and solvent for prolonged-release suspension for injection. The company was founded in 2008 and is based in Taipei, Taiwan.
